NTLA - Intellia Therapeutics, Inc.
IEX Last Trade
11.81
-0.090 -0.762%
Share volume: 25,110
Last Updated: Fri 27 Dec 2024 05:30:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$11.90
-0.09
-0.76%
Summary score
18%
Profitability
25%
Dept financing
5%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.42%
Return on assets
-8.48%
Return on sales
-246.03%
Return on invested capital
32.21%
Total debt ratio
20.98%
Debt ratio change over timeo
-1.32%
Current Ratio
8.3%
Quick Ratio
8.3%
Cash Position Ratio
7.99%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.48%
Return on assets
-10.33%
Return on sales
1255.43%
Return on invested capital
-50.05%
Total debt ratio
17.52%
Debt ratio change over timeo
-1.37%
Current Ratio
9.21%
Quick Ratio
9.21%
Cash Position Ratio
8.6%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.37%
Return on assets
-9.05%
Return on sales
-394%
Return on invested capital
-38.7%
Total debt ratio
17.74%
Debt ratio change over time
-1.25%
Current Ratio
9.03%
Quick Ratio
9.03%
Cash Position Ratio
8.08%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-82.98%
Return on assets
-85.53%
Return on sales
116.51%
Return on invested capital
16.26%
Total debt ratio
-132.31%
Debt ratio change over time
-1.32%
Current Ratio
-15.59%
Quick Ratio
-15.59%
Cash Position Ratio
-15.04%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NTLA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.42% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.48% | 2.76% | 3.15% | 5.62% |
| Return on sales | -246.03% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 32.21% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 42% | 63% | 71% |
| Total debt ratio | 20.98% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.32% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 9.21% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 9.21% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 8.6% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 13% | 31% |
| Short-term ratios | NTLA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.48% | 13.77% | 13.25% | 3.8% |
| Return on assets | -10.33% | 2.43% | 1.89% | 3.09% |
| Return on sales | 1255.43% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -50.05% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 51% | 49% | 58% |
| Total debt ratio | 17.52% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.37% | 46.38% | -72.08% | 1.51% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 9.21% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 9.21% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 8.6% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 14% | 36% |